126 related articles for article (PubMed ID: 37704215)
41. Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms.
Fossati N; Sjoberg DD; Capitanio U; Gandaglia G; Larcher A; Nini A; Mirone V; Vickers AJ; Montorsi F; Briganti A
BJU Int; 2015 Sep; 116(3):366-72. PubMed ID: 25168453
[TBL] [Abstract][Full Text] [Related]
42. Comparison of nomograms predicting lymph node invasion in patients undergoing radical prostatectomy for prostate cancer.
Nason GJ; O'Connor EM; MacMahon D; Moss B; Considine SW; Cahill A; O'Rourke C; O'Brien FM
Ir J Med Sci; 2018 Feb; 187(1):33-37. PubMed ID: 28478609
[TBL] [Abstract][Full Text] [Related]
43. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
Alberts AR; Roobol MJ; Verbeek JFM; Schoots IG; Chiu PK; Osses DF; Tijsterman JD; Beerlage HP; Mannaerts CK; Schimmöller L; Albers P; Arsov C
Eur Urol; 2019 Feb; 75(2):310-318. PubMed ID: 30082150
[TBL] [Abstract][Full Text] [Related]
44. Preoperative prediction of pelvic lymph nodes metastasis in prostate cancer using an ADC-based radiomics model: comparison with clinical nomograms and PI-RADS assessment.
Liu X; Wang X; Zhang Y; Sun Z; Zhang X; Wang X
Abdom Radiol (NY); 2022 Sep; 47(9):3327-3337. PubMed ID: 35763053
[TBL] [Abstract][Full Text] [Related]
45. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
[TBL] [Abstract][Full Text] [Related]
46. Comparison between Briganti, Partin and MSKCC tools in predicting positive lymph nodes in prostate cancer: a systematic review and meta-analysis.
Cimino S; Reale G; Castelli T; Favilla V; Giardina R; Russo GI; Privitera S; Morgia G
Scand J Urol; 2017 Oct; 51(5):345-350. PubMed ID: 28644701
[TBL] [Abstract][Full Text] [Related]
47. Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort.
Mottaghi M; Gu L; Deivasigamani S; Adams ES; Parrish J; Amling CL; Aronson WJ; Kane CJ; Terris MK; Guerrios-Rivera L; Cooperberg MR; Klaassen Z; Freedland SJ; Polascik TJ
Prostate Cancer Prostatic Dis; 2024 Apr; ():. PubMed ID: 38605270
[TBL] [Abstract][Full Text] [Related]
48. Development and external validation of a nomogram to predict lymph node invasion after robot assisted radical prostatectomy.
Tosco L; Devos G; De Coster G; Roumeguère T; Everaerts W; Quackels T; Dekuyper P; Van Cleynenbreugel B; Van Damme N; Van Eycken E; Ameye F; Joniau S;
Urol Oncol; 2020 Feb; 38(2):37.e11-37.e20. PubMed ID: 31727561
[TBL] [Abstract][Full Text] [Related]
49. Validation of models predicting lymph node involvement probability in patients with prostate cancer.
Blas L; Shiota M; Nagakawa S; Tsukahara S; Matsumoto T; Monji K; Kashiwagi E; Takeuchi A; Inokuchi J; Eto M
Int J Urol; 2022 May; 29(5):428-434. PubMed ID: 35102610
[TBL] [Abstract][Full Text] [Related]
50. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338
[TBL] [Abstract][Full Text] [Related]
51. External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
Hansen J; Rink M; Bianchi M; Kluth LA; Tian Z; Ahyai SA; Shariat SF; Briganti A; Steuber T; Fisch M; Graefen M; Karakiewicz PI; Chun FK
Prostate; 2013 Jan; 73(2):211-8. PubMed ID: 22821742
[TBL] [Abstract][Full Text] [Related]
52. External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer.
Milonas D; Venclovas Z; Muilwijk T; Jievaltas M; Joniau S
Cent European J Urol; 2020; 73(1):19-25. PubMed ID: 32395318
[TBL] [Abstract][Full Text] [Related]
53. First Nomogram Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients Undergoing Radioisotope Guided Sentinel Lymph Node Dissection.
Winter A; Kneib T; Rohde M; Henke RP; Wawroschek F
Urol Int; 2015; 95(4):422-8. PubMed ID: 26159232
[TBL] [Abstract][Full Text] [Related]
54. Expanding Active Surveillance Inclusion Criteria: A Novel Nomogram Including Preoperative Clinical Parameters and Magnetic Resonance Imaging Findings.
Lantz A; Falagario UG; Ratnani P; Jambor I; Dovey Z; Martini A; Lewis S; Lundon D; Nair S; Phillip D; Haines K; Cormio L; Carrieri G; Kryprianou N; Tewari A
Eur Urol Oncol; 2022 Apr; 5(2):187-194. PubMed ID: 32891599
[TBL] [Abstract][Full Text] [Related]
55. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer.
Sabbagh A; Washington SL; Tilki D; Hong JC; Feng J; Valdes G; Chen MH; Wu J; Huland H; Graefen M; Wiegel T; Böhmer D; Cowan JE; Cooperberg M; Feng FY; Roach M; Trock BJ; Partin AW; D'Amico AV; Carroll PR; Mohamad O
Eur Urol Oncol; 2023 Oct; 6(5):501-507. PubMed ID: 36868922
[TBL] [Abstract][Full Text] [Related]
56. A machine learning-assisted decision-support model to better identify patients with prostate cancer requiring an extended pelvic lymph node dissection.
Hou Y; Bao ML; Wu CJ; Zhang J; Zhang YD; Shi HB
BJU Int; 2019 Dec; 124(6):972-983. PubMed ID: 31392808
[TBL] [Abstract][Full Text] [Related]
57. Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators.
Mortezavi A; Palsdottir T; Eklund M; Chellappa V; Murugan SK; Saba K; Ankerst DP; Haug ES; Nordström T
Eur Urol Focus; 2021 May; 7(3):546-553. PubMed ID: 32451315
[TBL] [Abstract][Full Text] [Related]
58. External validation of the Memorial Sloan Kettering Cancer Center preoperative nomogram predicting lymph node invasion in a cohort of high-grade prostate cancer patients.
Touma N; Larose M; Ouellet J; Bédard-Tremblay D; Singbo N; Hovington H; Neveu B; Archambault L; Pouliot F
Prostate; 2024 May; ():. PubMed ID: 38800871
[TBL] [Abstract][Full Text] [Related]
59. Indication to pelvic lymph nodes dissection for prostate cancer: the role of multiparametric magnetic resonance imaging when the risk of lymph nodes invasion according to Briganti updated nomogram is <5.
Porpiglia F; Manfredi M; Mele F; Bertolo R; Bollito E; Gned D; De Pascale A; Russo F; Passera R; Fiori C; De Luca S
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):85-91. PubMed ID: 29472629
[TBL] [Abstract][Full Text] [Related]
60. Prediction of pathological stage at radical prostatectomy: do commonly used prostate cancer nomograms apply to men from Far North Queensland?
Nesbitt AL; Kapoor J; Piesse C; Evans G; Antoniou S; Smith P; Pridgeon SW
ANZ J Surg; 2019 Jan; 89(1-2):111-114. PubMed ID: 30560567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
